Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of food allergy: Immunotherapy, omalizumab, or both.
Brough HA, Kim EH, Anagnostou A, Lanser BJ, Chinthrajah RS, Sindher SB. Brough HA, et al. Among authors: chinthrajah rs. J Allergy Clin Immunol Pract. 2024 Dec 17:S2213-2198(24)01253-4. doi: 10.1016/j.jaip.2024.12.011. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39701277
Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II Study.
Sindher SB, Nadeau KC, Chinthrajah RS, Leflein JG, Bégin P, Ohayon JA, Ponda P, Wambre E, Liu J, Khokhar FA, Akinlade B, Maloney J, Orengo JM, Hamilton JD, Kamal MA, Hooper AT, Patel N, Patel K, Laws E, Mannent LP, Radin AR. Sindher SB, et al. Among authors: chinthrajah rs. Allergy. 2025 Jan;80(1):227-237. doi: 10.1111/all.16404. Epub 2024 Dec 14. Allergy. 2025. PMID: 39673452 Free PMC article. Clinical Trial.
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy.
Chinthrajah RS, Sindher SB, Nadeau KC, Leflein JG, Spergel JM, Petroni DH, Jones SM, Casale TB, Wang J, Carr WW, Shreffler WG, Wood RA, Wambre E, Liu J, Akinlade B, Atanasio A, Orengo JM, Hamilton JD, Kamal MA, Hooper AT, Patel K, Laws E, Mannent LP, Adelman DC, Ratnayake A, Radin AR. Chinthrajah RS, et al. Allergy. 2024 Dec 14. doi: 10.1111/all.16420. Online ahead of print. Allergy. 2024. PMID: 39673367
Management of eosinophilic esophagitis in pediatric patients undergoing oral immunotherapy for food allergies: A 2-center case series.
Hardwick G, Sia T, Bacchus L, Jia X, Chin AR, Khavari N, El Haija MA, McGhee S, Chinthrajah RS, Leung J, Sindher SB. Hardwick G, et al. Among authors: chinthrajah rs. J Allergy Clin Immunol Pract. 2024 Nov 28:S2213-2198(24)01195-4. doi: 10.1016/j.jaip.2024.11.016. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39615749 No abstract available.
10 practical priorities to prevent and manage serious allergic reactions: GA2LEN ANACare and EFA Anaphylaxis Manifesto.
Muraro A, de Silva D, Podesta M, Anagnostou A, Cardona V, Halken S, Smith P, Tanno LK, Turner P, Worm M, Alvaro-Lozano M, Arasi S, Asarnoj A, Barni S, Beyer K, Bilaver LA, Bird A, Bonaguro R, Brough HA, Chinthrajah RS, Cook EE, Demoulin C, Deschildre A, Dribin TE, Ebisawa M, Fernandez-Rivas M, Fiocchi A, Fleischer DM, Garrow E, Gerdts J, Giovannini M, Järvinen KM, Kelly M, Knol EF, Lack G, Lazzarotto F, Le TM, Leonard S, Lieberman J, Makris M, Mandelbaum L, Marchisotto MJ, Marino GA, Mori F, Nilsson C, Nowak-Wegrzyn A, Odemyr M, Oude Elberink HNG, Palosuo K, Patel N, Pier J, Poblete S, Rachid R, Rodríguez Del Río P, Said M, Sampson HA, Sánchez Sanz A, Schnadt S, Schultz F, Toniolo A, Upton JEM, Venter C, Vickery BP, Vlieg-Boerstra B, Wang J, Roberts G, Zuberbier T; GA2LEN ANACare Centres and EFA. Muraro A, et al. Among authors: chinthrajah rs. Clin Transl Allergy. 2024 Dec;14(12):e70009. doi: 10.1002/clt2.70009. Clin Transl Allergy. 2024. PMID: 39614094 Free PMC article. Review.
Baseline epitope-specific IgE profiles are predictive of sustained unresponsiveness or high threshold 1-year post oral immunotherapy in the POISED trial.
Suprun M, Lee ASE, Getts R, Peck S, Sindher SB, Nadeau KC, Chinthrajah RS, Galli SJ, Sampson HA. Suprun M, et al. Among authors: chinthrajah rs. J Allergy Clin Immunol. 2024 Nov 5:S0091-6749(24)01161-8. doi: 10.1016/j.jaci.2024.10.017. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39505279
Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?
Fiocchi A, Chinthrajah RS, Ansotegui IJ, Sriaroon P, Mustafa SS, Raut P, Cameron B, Gupta S, Fleischer DM. Fiocchi A, et al. Among authors: chinthrajah rs. J Asthma Allergy. 2024 Sep 17;17:889-900. doi: 10.2147/JAA.S475517. eCollection 2024. J Asthma Allergy. 2024. PMID: 39309477 Free PMC article.
Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH Study.
Vickery BP, Bird JA, Chinthrajah RS, Jones SM, Keet CA, Kim EH, Leung DYM, Shreffler WG, Sicherer SH, Sindher S, Spergel J, Wood RA. Vickery BP, et al. Among authors: chinthrajah rs. J Allergy Clin Immunol Pract. 2024 Nov;12(11):2947-2954. doi: 10.1016/j.jaip.2024.08.056. Epub 2024 Sep 16. J Allergy Clin Immunol Pract. 2024. PMID: 39293782
Asthma management in the digital age.
Bocian IY, Chin AR, Rodriguez A, Collins W, Sindher SB, Chinthrajah RS. Bocian IY, et al. Among authors: chinthrajah rs. Front Allergy. 2024 Sep 3;5:1451768. doi: 10.3389/falgy.2024.1451768. eCollection 2024. Front Allergy. 2024. PMID: 39291253 Free PMC article. Review.
104 results